On June 17, 2024, TG Therapeutics, Inc announced that it held its annual general meeting of shareholders on June 14, 2024, and declared voting results. Accordingly, the Company shareholders elected the board nominees: Laurence N. Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Sagar Lonial, and Michael S. Weiss, to the Company board to hold office until the 2025 annual meeting.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.79 USD | -0.89% | +0.79% | +4.16% |
17/06 | Declaration of Voting Results by TG Therapeutics | CI |
17/06 | Declaration of Voting Results by TG Therapeutics | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.16% | 2.57B | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- TGTX Stock
- News TG Therapeutics, Inc.
- Declaration of Voting Results by TG Therapeutics